Compare ENLT & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ENLT | TWST |
|---|---|---|
| Founded | 2008 | 2013 |
| Country | Israel | United States |
| Employees | 406 | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 9.2B |
| IPO Year | 2022 | 2018 |
| Metric | ENLT | TWST |
|---|---|---|
| Price | $68.77 | $179.82 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 8 |
| Target Price | ★ $48.83 | $46.88 |
| AVG Volume (30 Days) | 142.8K | ★ 1.8M |
| Earning Date | 05-05-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 63.89 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $376,572,000.00 |
| Revenue This Year | $403.69 | $18.91 |
| Revenue Next Year | N/A | $15.07 |
| P/E Ratio | $76.10 | ★ N/A |
| Revenue Growth | N/A | ★ 20.32 |
| 52 Week Low | $29.65 | $23.30 |
| 52 Week High | $108.65 | $186.20 |
| Indicator | ENLT | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 35.48 | 70.26 |
| Support Level | $65.61 | $41.18 |
| Resistance Level | $78.17 | N/A |
| Average True Range (ATR) | 1.72 | 11.17 |
| MACD | -0.25 | 3.45 |
| Stochastic Oscillator | 7.16 | 87.21 |
Enlight Renewable Energy Ltd develops, finances, constructs, owns, and operates utility-scale renewable energy projects. The company's operating segments are the MENA segment, Europe segment, U.S.A segment, and Others. It generates the majority of its revenue from the Europe segment, producing its revenue from the sale of the electricity which is produced through wind energy and solar energy in Europe.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.